Aspira Women's Health Inc. (AWH): Price and Financial Metrics
AWH Price/Volume Stats
Current price | $3.43 | 52-week high | $6.75 |
Prev. close | $3.50 | 52-week low | $2.31 |
Day low | $3.30 | Volume | 24,700 |
Day high | $3.51 | Avg. volume | 32,313 |
50-day MA | $4.29 | Dividend yield | N/A |
200-day MA | $3.99 | Market Cap | 35.46M |
AWH Stock Price Chart Interactive Chart >
AWH POWR Grades
- Growth is the dimension where AWH ranks best; there it ranks ahead of 92.02% of US stocks.
- AWH's strongest trending metric is Growth; it's been moving up over the last 160 days.
- AWH ranks lowest in Momentum; there it ranks in the 7th percentile.
AWH Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for AWH is -13.93 -- better than just 1.14% of US stocks.
- With a year-over-year growth in debt of -25.45%, ASPIRA WOMEN'S HEALTH INC's debt growth rate surpasses merely 12.81% of about US stocks.
- In terms of volatility of its share price, AWH is more volatile than 92.45% of stocks we're observing.
- Stocks with similar financial metrics, market capitalization, and price volatility to ASPIRA WOMEN'S HEALTH INC are WRAP, LIQT, ECOR, ASPN, and PLAB.
- AWH's SEC filings can be seen here. And to visit ASPIRA WOMEN'S HEALTH INC's official web site, go to www.vermillion.com.
AWH Valuation Summary
- In comparison to the median Healthcare stock, AWH's price/earnings ratio is 106.86% lower, now standing at -2.
- Over the past 243 months, AWH's price/earnings ratio has gone up 5.2.
Below are key valuation metrics over time for AWH.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
AWH | 2023-12-29 | 4.6 | -64.0 | -2.0 | -1.9 |
AWH | 2023-12-28 | 4.6 | -64.6 | -2.0 | -1.9 |
AWH | 2023-12-27 | 4.2 | -59.2 | -1.9 | -1.7 |
AWH | 2023-12-26 | 3.8 | -53.0 | -1.7 | -1.5 |
AWH | 2023-12-22 | 3.3 | -45.4 | -1.4 | -1.3 |
AWH | 2023-12-21 | 2.9 | -39.9 | -1.3 | -1.1 |
AWH Growth Metrics
- The year over year revenue growth rate now stands at 46.32%.
- Its 4 year cash and equivalents growth rate is now at 2.98%.
- Its 3 year price growth rate is now at -70.15%.
The table below shows AWH's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 7.882 | -32.758 | -31.03 |
2022-06-30 | 7.476 | -32.127 | -36.179 |
2022-03-31 | 7.209 | -32.313 | -35.01 |
2021-12-31 | 6.812 | -27.395 | -31.662 |
2021-09-30 | 6.407 | -24.503 | -28.782 |
2021-06-30 | 5.98 | -19.569 | -23.362 |
AWH's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- AWH has a Quality Grade of F, ranking ahead of 4.5% of graded US stocks.
- AWH's asset turnover comes in at 0.15 -- ranking 221st of 682 Pharmaceutical Products stocks.
- CLSN, DRRX, and RVNC are the stocks whose asset turnover ratios are most correlated with AWH.
The table below shows AWH's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.150 | 0.328 | -20.812 |
2021-03-31 | 0.170 | 0.288 | -20.376 |
2020-12-31 | 0.289 | 0.266 | -41.375 |
2020-09-30 | 0.308 | 0.337 | 116.497 |
2020-06-30 | 0.339 | 0.313 | 48.442 |
2020-03-31 | 0.337 | 0.304 | 38.632 |
AWH Price Target
For more insight on analysts targets of AWH, see our AWH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $12.00 | Average Broker Recommendation | 1.25 (Strong Buy) |
Aspira Women's Health Inc. (AWH) Company Bio
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Latest AWH News From Around the Web
Below are the latest news stories about ASPIRA WOMEN'S HEALTH INC that investors may wish to consider to help them evaluate AWH as an investment opportunity.
Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024AUSTIN, Texas, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that it will host a virtual R&D day featuring experts who will present the exciting progress of the company’s product pipeline on January 4, 2024 at 11:00 AM ET. To register, click here. Upcoming R&D Day: Aspira R&D Day: Updates on the Development of |
Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024Aspira management will be available for meetings in San Francisco (January 8-10, 2024) AUSTIN, Texas, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that management will be available for partnering and institutional one-on-one meetings in San Francisco, during JP Morgan’s Healthcare Conference Week 2024. Nicole |
New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PTNew to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10;30 PM PT Episode 537: 1). Reliance Global Group, Inc. (NASDAQ: RELI) (NASDAQ: RELIW) ($RELI) 2). Aspira Women's Health (NASDAQ: AWH) ($AWH) 3). Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP) 4).The Business of Blockchain, 5).Sekur Private Data, Ltd. (OTCQB: SWISF) (CSE: SKUR) (FRA: GDT0) (Sekur®) - https://www.newtothestreet.com/ NEW YORK, Dec. 08, 202 |
New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PTNew to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT Episode 536: 1). - Reliance Global Group, Inc. (NASDAQ: RELI) (NASDAQ: RELIW) ($RELI) 2). Aspira Women's Health (NASDAQ: AWH) ($AWH) 3). Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP) 4). The Business of Blockchain 5).Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) (Sekur®) - https://www.ne |
Aspira Women’s Health Provides a Development Update on its Portfolio of Noninvasive Tests for EndometriosisData supports EndoCheck™ to be the first blood test for the identification of localized endometriosis, including endometrioma Platform migration to begin on the Company’s EndoMDx™ test for broader endometriosis indications AUSTIN, Texas, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that it has completed the de |
AWH Price Returns
1-mo | -15.31% |
3-mo | -15.93% |
6-mo | -36.01% |
1-year | -36.88% |
3-year | -96.52% |
5-year | -80.12% |
YTD | -15.93% |
2023 | -18.22% |
2022 | -81.21% |
2021 | -73.62% |
2020 | 728.40% |
2019 | 170.00% |
Loading social stream, please wait...